Methotrexate: new indication. Psoriatic arthritis: approved at last.
Efficacy is mainly based on long experience but must be weighed against potentially severe adverse effects.
D018501:Antirheumatic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D015535:Arthritis, Psoriatic / Q000188:drug therapy*; D017277:Drug Approval; D005602:France; D006801:Humans; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic
D018501:Antirheumatic Agents; D008727:Methotrexate